Finding published adverse drug effects of anti-retroviral agents, using evidence-based approach.
- At: 2008 FIP Congress in Basel (Switzerland)
- Type: Poster
- By: ABRANTES, Catarina (Faculty Pharmacy, University Coimbra, Coimbra, Portugal)
- Co-author(s): Ribeiro Rama, Ana Cristina (Coimbra University Hospitals, Pharmacy, Portugal)
Caramona, Maria Margarida (Faculty Pharmacy, University Coimbra, Portugal)
Fernandez-Llimos, Fernando (Faculty Pharmacy, University Lisbon, Portugal)
Figueiredo, Isabel Vitória (Faculty Pharmacy, University Coimbra, COIMBRA, Portugal)
Meliço Silvestre, António (Faculty Medicine, University Coimbra, Portugal)
Development of new anti-retroviral agents (ARa), along with implementation of combined therapeutic regimes, is a true turning-point for treatment of HIV infection, allowing control of disease progress, increase in survival and improvement of virological and immunological responses. Nevertheless, adverse effects(1) can determine noncompliance,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.